Search - tctmd.com

Displaying 641 - 660 of 1103

Sort: Relevancy | Date

News Daily News

Higher Fitness Again Tied to a Lower Risk of Death, Including CVD Mortality

Michael O'Riordan

October 30, 2018

News Daily News

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

Shelley Wood

October 29, 2018

News Daily News

Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis

Todd Neale

October 26, 2018

News Daily News

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Michael O'Riordan

October 25, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

L.A. McKeown

October 18, 2018

News Daily News

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

L.A. McKeown

October 16, 2018

News Daily News

Beta-blocker Use in Pregnancy Doesn’t Up Birth Defect Risk, Study Suggests

Caitlin E. Cox

October 15, 2018

News Daily News

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Michael O'Riordan

October 15, 2018

News Daily News

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

Michael O'Riordan

October 08, 2018

News Daily News

Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT

Shelley Wood

September 24, 2018

News Daily News

Aspirin Falters Yet Again in Primary Prevention: ASPREE

Michael O'Riordan

September 17, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Conference News ESC 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Todd Neale

August 26, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Daily News

Hospital Readmissions at 30 Days Declining for Stroke Patients

Michael O'Riordan

August 20, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

Todd Neale

August 13, 2018

Advertisement

Higher Fitness Again Tied to a Lower Risk of Death, Including CVD Mortality

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

Beta-blocker Use in Pregnancy Doesn’t Up Birth Defect Risk, Study Suggests

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT

Aspirin Falters Yet Again in Primary Prevention: ASPREE

TCTMD’s Top 10 Most Popular Stories for August 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Hospital Readmissions at 30 Days Declining for Stroke Patients

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content